Symposium will bring together experts from around the world to foster innovation in cancer research and patient careHOBOKEN, NJ-The University of ...

An MD Anderson team led by Amir Jazaeri, MD, takes a pioneering approach to finding residual ovarian cancer cells.

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, ...

A study compares second-look laparoscopy and circulating tumor DNA (ctDNA) to detect residual ovarian cancer and predict ...

Prostate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

AdventHealth Cancer Institute Shawnee Mission in the Kansas City area will remain an independent entity but align with UChicago Medicine when it comes to standards in clinical care, medical ...

Surgery and liquid biopsy can be used to detect minimal residual disease following frontline treatment for ovarian cancer, ...

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation, ...

ROCHESTER — Nucleus RadioPharma, the downtown Rochester-based, Mayo Clinic-co-founded radioactive drug maker, has a new chief ...

Nucleus RadioPharma, a next-generation contract development and manufacturing organization (CDMO) specializing in ...